4.7 Letter

Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a κ opioid receptor antagonist

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 45, Issue 26, Pages 5617-5619

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm025575g

Keywords

-

Funding

  1. NIDA NIH HHS [R01 DA05195, F01 DA15029] Funding Source: Medline

Ask authors/readers for more resources

Arodyn (aromatic dynorphin) is a novel analogue of the opioid peptide dynorphin A with a nonbasic N-terminus that exhibits nanomolar affinity (K-i = 10 nM) and remarkable selectivity for kappa opioid receptors (K-i ratio (kappa/mu/delta) = 1/174/583). Arodyn completely reverses the agonism of dynorphin A (1-13)NH2 in a concentration-dependent manner in the adenylyl cyclase assay. Thus arodyn is a novel K opioid receptor selective antagonist that will be useful to study these receptors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available